Shashank Rameshchandra Joshi
7PUBLICATIONS
173CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 11, 2026
Efficacy and safety of fixed-dose dapagliflozin-pioglitazone in Indian adults with type 2 diabetes: a phase 3 PRO-1 trial.Awadhesh Kumar Singh, Krishna G Seshadri, A G Unnikrishnan
|Dec 10, 2025
Effectiveness and safety of saroglitazar in managing dyslipidaemia and liver enzymes in patients with type 2 diabetes, MASLD, and Stage 3 chronic kidney disease: A 12-month observational study.Gaurab Bhaduri, Shambo S Samajdar, Sanjay Bandyopadhyay
|Oct 27, 2025
Semaglutide beyond weight loss: Mechanistic insights and functional paradoxes from the SEMALEAN study.Shambo S Samajdar, Shashank Joshi
|Oct 01, 2025
Postprandial Glucose: A Variable in Continuum.Shashank Joshi, Jothydev Kesavadev, Prasanna Kumar K M
|Jun 03, 2025
Management of metabolic dysfunction-associated steatotic liver disease (MASLD)-An expert consensus statement from Indian diabetologists' perspective.Abdul Hamid Zargar, Anil Bhansali, Anirban Majumdar
|Oct 06, 2024
The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose Monitors.David C Klonoff, Guido Freckmann, Stefan Pleus
Pageof 2
Frequent Collaborators
2 joint publications
David C Klonoff
2 joint publications
Jing Wang
2 joint publications
Michael A Kohn
2 joint publications
Chengdong Li
2 joint publications
Gregg Simonson
2 joint publications
David Kerr
2 joint publications
David T Ahn
2 joint publications
Anne L Peters
2 joint publications
Guillermo E Umpierrez
2 joint publications
Jane Jeffrie Seley
